Tumour suppressor PTEN activity is differentially inducible by myo‐inositol phosphates

por Grzymajlo, Krzysztof, El Hafny‐Rahbi, Bouchra, Kieda, Claudine
Publicado 2023

Hypoxia-shaped vascular niche for cancer stem cells

por Collet, Guillaume, El Hafny-Rahbi, Bouchra, Nadim, Mahdi, Tejchman, Anna, Klimkiewicz, Krzysztof, Kieda, Claudine
Publicado 2015

Tumour angiogenesis normalized by myo‐inositol trispyrophosphate alleviates hypoxia in the microenvironment and promotes antitumor immune response

por El Hafny‐Rahbi, Bouchra, Brodaczewska, Klaudia, Collet, Guillaume, Majewska, Aleksandra, Klimkiewicz, Krzysztof, Delalande, Anthony, Grillon, Catherine, Kieda, Claudine
Publicado 2021

Treatment of hypoxia‐dependent cardiovascular diseases by myo‐inositol trispyrophosphate (ITPP)‐enhancement of oxygen delivery by red blood cells

por Oknińska, Marta, El‐Hafny‐Rahbi, Bouchra, Paterek, Aleksandra, Mackiewicz, Urszula, Crola‐Da Silva, Claire, Brodaczewska, Klaudia, Mączewski, Michał, Kieda, Claudine
Publicado 2020

Stable tumor vessel normalization with pO(2) increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment

por Kieda, Claudine, El Hafny-Rahbi, Bouchra, Collet, Guillaume, Lamerant-Fayel, Nathalie, Grillon, Catherine, Guichard, Alan, Dulak, Jozef, Jozkowicz, Alicja, Kotlinowski, Jerzy, Fylaktakidou, Konstantina C., Vidal, Aurélien, Auzeloux, Philippe, Miot-Noirault, Elisabeth, Beloeil, Jean-Claude, Lehn, Jean-Marie, Nicolau, Claude
Publicado 2013